Natalia Camejo
University of the Republic
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Natalia Camejo.
Journal of Clinical Oncology | 2015
Andrea Schiavone; Mariana Díaz; Natalia Camejo; Natalia Reborido; Horacio Vázquez; Gabriel Parma; Álvaro Vázquez; Cecilia Castillo; Gabriel Krygier; Lucía Delgado
143 Background: To evaluate the incidence, severity and outcome of Trastuzumab-induced cardiotoxicity in HER2 positive Uruguayan breast cancer (BC) patients. METHODS Retrospective observational analysis of HER2 positive BC patients who were treated with Trastuzumab (TTZ) from January 2007 to December 2013 at two Uruguayan centers. Cardiac monitoring included physical examination and assessment of left ventricular ejection fraction (LVEF) by echocardiography that was evaluated before TTZ administration and every 12 weeks thereafter during the duration of therapy. Cardiovascular risk factors analyzed were: obesity (BMI ≥ 30 kg/m2), hypertension, diabetes, sedentary lifestyle and high cholesterol. RESULTS Sixty nine female patients were found in the databases of our institutions. Median age was 48 years (range: 27-73). Stage at diagnosis was as detailed: 19 % EI, 46 % EII, 29 % EIII and 4 % EIV. Eighty nine percent of patients received adjuvant TTZ , 4 % neoadjuvant TTZ and 7 % received it as a palliative therapy. Thirty patients (43, 5%) had at least one cardiovascular risk factors: 26% hypertension, 16% obesity, 9% sedentary lifestyle, and 4% high cholesterol. Median number of TTZ cycles was 15. Cycles were administered every 3 weeks at standard dose. Nineteen patients (27%) developed cardiotoxicity, of whom 12 had a transient suspension because of a reversible fall in LVEF, 2 had a irreversible reduction in LVEF, and 5 had a symptomatic heart failure. Eighty-nine percent of our patients (62 patients) completed treatment and the rest had a definitive suspension due to a irreversible reduction in LVEF or symptomatic heart failure. Most patients that developed cardiotoxicity (15 out of 19) had cardiovascular risk factors and also most of them (16 out of 19) had received anthracyclines before TTZ. CONCLUSIONS Cardiotoxicity incidence was similar to the incidence reported in the literature and when it was present, in most cases was transient, asymptomatic, and reversible.
Revista Médica del Uruguay | 2010
Lucía Delgado; Rodrigo Fresco; Guianeya Santander; Sergio Aguiar; Natalia Camejo; Liliana Ferrero; Valeria González; Silvina Heinzen; Andrea Martínez; Samantha Mauriz; Carlos Meyer; Gustavo Sena; Gonzalo Spera; Luis Ubillos; Franco Xavier; Hugo Deneo; Marta Aghazarian; Robinson Rodríguez; Graciela Sabini
Journal of Clinical Oncology | 2016
Lucía Delgado; R. Fresco; G. Santander; S. Aguiar; Natalia Camejo; L. Ferrero; V. Gonzalez; S. Heinzen; A. Martinez; G. Sabini
Revista Médica del Uruguay | 2012
Cecilia Castillo; Natalia Camejo; Lucía Delgado; Rodrigo Fresco; Guianeya Santander; Sergio Aguiar; Valeria González; Silvina Heinzen; Andrea Martínez; Carlos Meyer; Gustavo Sena; Gonzalo Spera; Luis Ubillos; Franco Xavier; Hugo Deneo; Marta Aghazarian; Robinson Rodríguez; Graciela Sabini
Journal of Clinical Oncology | 2011
Natalia Camejo; V. Gonzalez; Cecilia Castillo; Lucía Delgado; L. Ferrero; R. Fresco; G. Santander; S. Aguiar; S. Heinzen; A. Martinez; C. Meyer; G. Sena; G. Spera; L. Ubillos; F. Xavier; R. Rodríguez; G. Sabini
Revista Uruguaya de Medicina Interna | 2018
Cecilia Cecilia; Natalia Camejo; Nora Artagaveytia; Ana Hernandez; Lucía Delgado
Journal of Clinical Oncology | 2018
Natalia Camejo; Cecilia Castillo; Rafael Alonso; Emiliano Rivero; Camila Mezquita; Agustin Rosich; Fiamma Dellacasa; Luciana Silveira; Jonathan Nuñez; Lucía Delgado
Anales de la Facultad de Medicina | 2018
Natalia Camejo; Cecilia Castillo; Andrea Shiavone; Ana Laura Alfonso; Dahiana Amarillo; Franco Xavier; Gabriel Krygier; Lucía Delgado
Revista Médica del Uruguay | 2017
Silvina Malvasio; Andrea Schiavone; Natalia Camejo; Cecilia Castillo; Nora Artagaveytia; Carina Di Matteo; Benedicta Caserta; Roberto Notejane; Isabel Alonso; Lucía Delgado
Journal of Clinical Oncology | 2017
Natalia Camejo; Cecilia Castillo; Lucía Richter; Nora Artagaveytia; Ana Hernandez; Lucía Delgado